APA (7th ed.) Citation

Pandey, U., Kameswaran, M., Gamre, N., & Dash, A. (2019). Preparation of 177Lu‐labeled Nimotuzumab for radioimmunotherapy of EGFR‐positive cancers: Comparison of DOTA and CHX‐A″‐DTPA as bifunctional chelators. Journal of Labelled Compounds & Radiopharmaceuticals, 62(4), 158. https://doi.org/10.1002/jlcr.3707

Chicago Style (17th ed.) Citation

Pandey, Usha, Mythili Kameswaran, Naresh Gamre, and Ashutosh Dash. "Preparation of 177Lu‐labeled Nimotuzumab for Radioimmunotherapy of EGFR‐positive Cancers: Comparison of DOTA and CHX‐A″‐DTPA as Bifunctional Chelators." Journal of Labelled Compounds & Radiopharmaceuticals 62, no. 4 (2019): 158. https://doi.org/10.1002/jlcr.3707.

MLA (9th ed.) Citation

Pandey, Usha, et al. "Preparation of 177Lu‐labeled Nimotuzumab for Radioimmunotherapy of EGFR‐positive Cancers: Comparison of DOTA and CHX‐A″‐DTPA as Bifunctional Chelators." Journal of Labelled Compounds & Radiopharmaceuticals, vol. 62, no. 4, 2019, p. 158, https://doi.org/10.1002/jlcr.3707.